Phase I study of AMG 509, a STEAP1 x CD3 T-cell recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Kelly, W. K.; Pook, D. W.; Appleman, L. J.; Waterhouse, D. M.; Horvath, L.; Edenfield, W. J.; Matsubara, N.; Danila, D. C.; Aggarwal, R. R.; Petrylak, D. P.; Sartor, O. A.; Sumey, C. J.; Adra, N.; Armstrong, A. J.; Cheng, F. C.; Stieglmaier, J.; Kouros-Mehr, H.; Dorff, T. B. |
| Abstract Title: | Phase I study of AMG 509, a STEAP1 x CD3 T-cell recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2021 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2021 Feb 11-13 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-02-20 |
| Language: | English |
| ACCESSION: | WOS:000636801500014 |
| DOI: | 10.1200/JCO.2021.39.6_suppl.TPS183 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS183 -- Source: Wos |
